Junjie Shen

3.5k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Junjie Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junjie Shen has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Junjie Shen's work include RNA modifications and cancer (8 papers), CAR-T cell therapy research (8 papers) and Cancer Cells and Metastasis (7 papers). Junjie Shen is often cited by papers focused on RNA modifications and cancer (8 papers), CAR-T cell therapy research (8 papers) and Cancer Cells and Metastasis (7 papers). Junjie Shen collaborates with scholars based in China, Spain and United States. Junjie Shen's co-authors include Cheng Qian, Juanjuan Shan, Zhi Yang, Yanmin Xu, Leina Ma, Xiu‐Wu Bian, Limei Liu, Chungang Liu, Yimin Chai and You‐Hong Cui and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Junjie Shen

61 papers receiving 2.4k citations

Hit Papers

Bispecific Antibodies: From Research to Clinical Application 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bispecific Antibodies: From Research to Clinical Application
    2021 220 citations Junjie Shen, Yanan Qi et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjie Shen China 25 1.3k 761 571 227 206 65 2.4k
Zhi Yang China 30 1.6k 1.3× 891 1.2× 832 1.5× 306 1.3× 310 1.5× 113 3.0k
Yun Yang China 26 1.5k 1.1× 832 1.1× 850 1.5× 194 0.9× 318 1.5× 86 2.7k
Lin Xu China 23 1.2k 0.9× 802 1.1× 345 0.6× 190 0.8× 243 1.2× 65 2.3k
Laura Annaratone Italy 27 1.1k 0.9× 787 1.0× 688 1.2× 102 0.4× 225 1.1× 68 2.2k
Yanan Kong China 28 1.7k 1.3× 1.3k 1.8× 699 1.2× 186 0.8× 215 1.0× 78 2.8k
Serk In Park United States 27 1.2k 0.9× 472 0.6× 1.1k 2.0× 294 1.3× 178 0.9× 57 2.3k
Jonathan Gill United States 21 1.4k 1.1× 824 1.1× 957 1.7× 451 2.0× 177 0.9× 84 3.0k
Zhongwei Zhao China 31 1.1k 0.9× 682 0.9× 417 0.7× 328 1.4× 102 0.5× 115 2.6k
François Lamoureux France 31 1.6k 1.2× 567 0.7× 830 1.5× 216 1.0× 126 0.6× 73 2.5k
Olivier Dormond Switzerland 33 1.7k 1.4× 584 0.8× 1.1k 2.0× 422 1.9× 260 1.3× 72 3.3k

Countries citing papers authored by Junjie Shen

Since Specialization
Citations

This map shows the geographic impact of Junjie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Shen more than expected).

Fields of papers citing papers by Junjie Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Shen. The network helps show where Junjie Shen may publish in the future.

Co-authorship network of co-authors of Junjie Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Shen. A scholar is included among the top collaborators of Junjie Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Shen. Junjie Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
He, Xue, Bin Hu, Yingzi Zhang, et al.. (2024). Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells. Autoimmunity Reviews. 24(1). 103692–103692. 18 indexed citations
4.
Hong, Hui, Yonghui Zhang, Zhiqin Xie, et al.. (2024). Development and preliminary validation of a PROS scale for Chinese bladder cancer patients with abdominal stoma. Scientific Reports. 14(1). 2187–2187. 1 indexed citations
5.
Shen, Junjie, et al.. (2024). Long non-coding RNA GATA6-AS1 is mediated by N6-methyladenosine methylation and inhibits the proliferation and metastasis of gastric cancer. World Journal of Gastrointestinal Oncology. 16(3). 1019–1028. 2 indexed citations
6.
Zhang, Leyang, et al.. (2023). Tissue mechanics modulate PCNP expression in oral squamous cell carcinomas with different differentiation. Frontiers in Oncology. 12. 1072276–1072276. 1 indexed citations
7.
Shen, Junjie, et al.. (2023). SH-BAW devices with abnormal mass-loading effect for chemical sensing. Applied Physics Letters. 123(20).
8.
9.
Shen, Junjie, et al.. (2023). Baicalein facilitates gastric cancer cell apoptosis by triggering endoplasmic reticulum stress via repression of the PI3K/AKT pathway. Applied Biological Chemistry. 66(1). 10–10. 14 indexed citations
10.
Yu, Yaling, Huimin Xiao, Guoke Tang, et al.. (2023). Biomimetic hydrogel derived from decellularized dermal matrix facilitates skin wounds healing. Materials Today Bio. 21. 100725–100725. 25 indexed citations
11.
Chen, Gong, Ke Zhang, Lei Zhou, et al.. (2022). Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials. Frontiers in Cardiovascular Medicine. 9. 926979–926979. 10 indexed citations
12.
Shen, Junjie, et al.. (2021). Bispecific Antibodies: From Research to Clinical Application. Frontiers in Immunology. 12. 626616–626616. 220 indexed citations breakdown →
13.
Chen, Xuejiao, Hong-Bo Huan, Chungang Liu, et al.. (2019). Deacetylation of β-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells. Cancer Letters. 463. 1–10. 37 indexed citations
14.
Su, Li, Yongli Luo, Zhi Yang, et al.. (2016). MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer. Cancer Research. 76(17). 5054–5067. 57 indexed citations
15.
Cheng, Feifei, Li Su, Chao Yao, et al.. (2016). SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Letters. 375(2). 274–283. 84 indexed citations
16.
Yang, Yongxin, Haineng Xu, Junjie Shen, et al.. (2015). RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells. Cell Death and Disease. 6(5). e1760–e1760. 23 indexed citations
17.
Xu, Yanmin, Leina Ma, Juanjuan Shan, et al.. (2015). MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Letters. 371(2). 171–181. 135 indexed citations
18.
Ma, Leina, Jia Liu, Limei Liu, et al.. (2014). Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes. Cancer Research. 74(5). 1452–1462. 74 indexed citations
19.
Xu, Yan, Dan Wang, Limei Zhao, et al.. (2013). Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells. Cancer Biology & Therapy. 14(10). 937–948. 10 indexed citations
20.
Shen, Junjie, et al.. (2010). Clinical Study of Transarterial Chemotherapy in Combination with Iodine-125 Seed Implantation in Treating the Advanced Pancreatic Carcinoma. 26(7). 1002–1005. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi Yang Breakdown of academic impact, for papers by Yun Yang Breakdown of academic impact, for papers by Lin Xu Breakdown of academic impact, for papers by Laura Annaratone Breakdown of academic impact, for papers by Yanan Kong Breakdown of academic impact, for papers by Serk In Park Breakdown of academic impact, for papers by Jonathan Gill Breakdown of academic impact, for papers by Zhongwei Zhao Breakdown of academic impact, for papers by François Lamoureux Breakdown of academic impact, for papers by Olivier Dormond
Rankless by CCL
2026